Zhejiang Garden Biopharmaceutical Co.,Ltd. (SHE:300401)
China
· Delayed Price · Currency is CNY 13.21
+0.06 (0.46%)
Apr 29, 2026, 3:04 PM CST
SHE:300401 Revenue
Zhejiang Garden Biopharmaceutical had revenue of 276.88M CNY in the quarter ending March 31, 2026, a decrease of -15.17%. This brings the company's revenue in the last twelve months to 1.19B, down -4.16% year-over-year. In the year 2025, Zhejiang Garden Biopharmaceutical had annual revenue of 1.24B, down -0.47%.
Revenue (ttm)
1.19B
Revenue Growth
-4.16%
P/S Ratio
6.05
Revenue / Employee
1.16M
Employees
1,021
Market Cap
7.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.24B | -5.88M | -0.47% |
| Dec 31, 2024 | 1.24B | 148.63M | 13.58% |
| Dec 31, 2023 | 1.09B | -322.86M | -22.78% |
| Jan 1, 2023 | 1.42B | 300.41M | 26.89% |
| Jan 1, 2022 | 1.12B | 457.66M | 69.40% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Jan 1, 2019 | Pro | Pro | Pro |
| Jan 1, 2018 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| KPC Pharmaceuticals,Inc. | 5.80B |
| Northeast Pharmaceutical Group | 7.13B |
| Jiangsu Yahong Meditech | 277.12M |
| Beijing SL Pharmaceutical | 578.61M |
| Zhejiang Tianyu Pharmaceutical | 3.11B |
| Zhejiang AngLiKang Pharmaceutical CO.,LTD. | 1.45B |
| Cisen Pharmaceutical | 3.44B |
| Guizhou Bailing Group Pharmaceutical | 3.05B |